24 May 2013
Keywords: kv, richter, gedeon, expand, license, deal, usa
Article | 12 December 2005
The USA's KV Pharmaceutical Co has concluded a long-term licensing agreement with Hungarian drug giant Richter Gedeon to market the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 January 2006
20 June 2005
23 May 2013
© 2013 thepharmaletter.com